STAMFORD, CT - APRIL 2: Purdue Pharma headquarters stands in downtown Stamford, April 2, 2019 in Stamford, Connecticut. Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, are facing hundreds of lawsuits across the country for the company's alleged role in the opioid epidemic that has killed more than 200,000 Americans over the past 20 years. (Photo by Drew Angerer/Getty Images)

(AP) – A federal appeals panel is considering whether to allow a legal move that would pave the way for a settlement between OxyContin maker Purdue Pharma and governments across the U.S. The deal would allow the company to exit bankruptcy and require members of the Sackler family who own it to contribute billions of dollars to help combat the opioid crisis in the U.S. At issue at a hearing Friday before the 2nd U.S. Circuit Court of Appeals in New York is whether a bankruptcy judge has the authority to grant members of the Sackler family protection from civil lawsuits over the toll of opioids.